Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: A phase III trial (CALGB 9583). Small EJ, Halabi S, Dawson NA, Stadler WM, Rini BI, Picus J, Gable P, Torti FM, Kaplan E, Vogelzang NJ, UCSF Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.
2004 ◽
Vol 22
(5)
◽
pp. 433
2004 ◽
Vol 22
(5)
◽
pp. 433-433
2013 ◽
Vol 31
(8)
◽
pp. 1846
2017 ◽
Keyword(s):
Keyword(s):
2013 ◽
Vol 16
(4)
◽
pp. 382-386
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3-3
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 9123-9123
◽
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. 4681-4681
◽
Keyword(s):